Screen Testing. Cardiovascular Prevention in Asymptomatic Diabetic Patients

Journal of the American College of Cardiology

Volumn 49, Issue 19, 2007, Pages 1915-1917

  Diamond, George A ^a   Kaul, Sanjay ^a   Shah, Prediman K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STATIN;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; COST BENEFIT ANALYSIS; DIABETIC PATIENT; HEART SCINTISCANNING; HUMAN; PRIORITY JOURNAL; REVIEW; SCREENING TEST; STRATEGIC PLANNING;

ATHEROSCLEROSIS; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MASS SCREENING;

EID: 34247891767     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.09.057     Document Type: Review

References (21)

1. Wilder B. director. Sunset Boulevard (film) (1950), Paramount Pictures, Los Angeles, CA
2. Bax J.J., Bonow R.O., Tschope D., Inzucchi S.E., and Barrett E. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48 (2006) 754-760
3. Miller T.D., Redberg R.F., and Wackers F.J.T. Screening asymptomatic diabetic patients for coronary artery disease. Why not?. J Am Coll Cardiol 48 (2006) 761-764
4. Sackett D.L., Haynes R.B., and Tugwell P. Early diagnosis. Clinical Epidemiology: A Basic Science for Clinical Medicine (1985), Little, Brown and Co, Boston, MA 144-155
5. Sackett D.L., Haynes R.B., and Tugwell P. How to read a clinical journal. Clinical Epidemiology: A Basic Science for Clinical Medicine (1985), Little, Brown and Co, Boston, MA 302-310
6. HVPA Cost Comparison-Statins/Statin Combos June 2006. Available at: http://www.hvpa.com/hvpa_rx_drug_cost_tables_files/statin_cost_comparisons_0606upd.pdf. Accessed July 27, 2006.
7. Physician Fee Schedule. Available at: http://www.cms.hhs.gov/PhysicianFeeSched/. Accessed July 27, 2006.
8. American Heart Association. Heart Disease and Stroke Statistics-2005 Update (2005), American Heart Association, Dallas, TX
9. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
10. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
11. Statistical Abstract of the United States. Table 116. Deaths-Life Years Lost and Mortality Costs by Age, Sex, and Cause: 2000 and 2002 (2006), U.S. Department of Commerce, Washington, DC 92
12. Grover S.A., Coupal L., Zowall H., Alexander C.M., Weiss T.W., and Gomes D.R.J. How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?. Diabetes Care 24 (2001) 45-50
13. Koch R. The 80/20 Principle (1998), Doubleday, New York, NY
14. Wackers F.J.T., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. Diabetes Care 27 (2004) 1954-1961
15. Rajagopalan N., Miller T.D., Hodge D.O., Frye R.L., and Gibbons R.J. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 45 (2005) 43-49
16. Zellweger M.J., Hachamovitch R., Kang X., et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 25 (2004) 543-550
17. Barsness G.W., Gersh B.J., Brooks M.M., Frye R.L., and BARI 2D Trial Investigators. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 97 (2006) 31G-40G
18. Naghavi M., Falk E., Hecht H.S., et al. From vulnerable plaque to vulnerable patient-part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 98 (2006) 2H-15H
19. Pfutzner A., and Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 8 (2006) 28-36
20. Clinton W.J. Executive Order 12866. Regulatory planning and review 58 (1993) 51735 Federal Register September 30
21. Diamond G.A., and Kaul S. Hazardous to your health. Kinetic foundations of risk stratification and therapeutic triage. Am J Med 119 (2006) 275 e1-6